Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (<i>KAL1</i>) and Fibroblast Growth Factor Receptor 1 (<i>FGFR1</i>, or<i>KAL2</i>) in Five Families and 18 Sporadic Patients

Naoko Sato(National Center For Child Health and Development), Tsutomu Ogata(National Center For Child Health and Development), Masato Yokozawa(Sapporo Medical University), Yasuhiro Naiki(National Center For Child Health and Development), S KAWAKITA, Aki Shimotsuka(Kushiro City General Hospital), Shigeru Minowada(Saitama International Medical Center), Toshiaki Tanaka(National Center For Child Health and Development), Yukihiro Hasegawa(Tokyo Metropolitan Children's Medical Center), Keisuke Nagasaki(Niigata University), Yoshimasa Shishiba, Tomonobu Hasegawa, Naoaki Hori, Toshiyuki Yasuda(Chiba Hospital), Daiichiro Hasegawa(Kobe Children's Hospital), Katsuhiko Tachibana(Kanagawa Children's Medical Center), Masayo Kagami(National Center For Child Health and Development), Noriyuki Katsumata, Reiko Horikawa(National Center For Child Health and Development)
The Journal of Clinical Endocrinology & Metabolism
March 1, 2004
Cited by 220


Related Papers